• Skip to primary navigation
  • Skip to main content

GAiT.Global

The Global Alliance for iPSC Therapies

  • About GAiT
    • About GAiT
    • Sponsors
      • NYSCF
      • KHiB
      • CCRM
      • INSERM / Cithera /INGESTEM
      • HKU
      • CGT
    • Support Us
  • News & Events
  • Publications
  • Workshops
  • iPSC Quality Assessment Rounds
    • iPSC Quality Assessment Round 2019
    • iPSC Quality Assessment Round 2022
      • iPSC Quality Assessment Round 2022 – Document Page
  • Directories
  • Clinical Database
  • Portal Login

Main Content

Welcome to GAiT

The Global Alliance for iPSC Therapies

Portal Log in Learn more

About Us

GAiT is an international resource to facilitate the therapeutic use of immunogenetically matched, clinical-grade new types of stem cells (iPSCs) for the benefit of patients globally.  GAiT’s vision is that patients globally will have equity of access to this new generation of iPSC-derived cell therapy products.

our mission

GAiT’s mission is to enable the global human community the opportunity to benefit from the new generation of cell therapies by facilitating the development of, and access to, clinical-grade and haplotyped induced pluripotent stem cells for the manufacture of cell therapy products.

Our Objectives

  • Achieve consensus on donor selection and screening criteria and consent standards.
  • Achieve global consensus on manufacturing and quality parameters and standards required to consider an iPSC line to be of clinical grade and develop an external quality assurance scheme to facilitate the development of comparability between centres.
  • Gain agreement with regulators in various jurisdictions as to the acceptability of the quality standards proposed.
  • Develop a database of clinical grade iPSC lines.

News & Events

The latest from GAiT

Find us on Twitter
Retweet on Twitter GAiT Retweeted
Signalsblogs avatar; Signals @Signalsblogs ·
2 Aug 1554460973074989056

What is a target product profile (TPP) and why should you have one for you CAR T-cell therapy? A guest blogger from @CCRM_au explains. https://www.signalsblog.ca/target-product-profile-starting-that-journey-of-a-thousand-miles-with-the-right-first-step/

Image for the Tweet beginning: What is a target product Twitter feed image.
Reply on Twitter 1554460973074989056 Retweet on Twitter 1554460973074989056 2 Like on Twitter 1554460973074989056 1 Twitter 1554460973074989056
IPSCtherapies avatar; GAiT @IPSCtherapies ·
29 Jul 1552810002238300161

We want safe and efficacious iPSC therapeutics that have clinical impact globally. Is Quality Testing consistent and indicative for your "clinical-grade" iPSCs? GAiT & @CiRA_F_J conduct iPSC Quality Assessment Rounds to assist efficient translation.

Image for the Tweet beginning: We want safe and efficacious Twitter feed image.
Reply on Twitter 1552810002238300161 Retweet on Twitter 1552810002238300161 0 Like on Twitter 1552810002238300161 2 Twitter 1552810002238300161
IPSCtherapies avatar; GAiT @IPSCtherapies ·
28 Jul 1552560791823564800

At day 2 of the iPSC Manufacturing Summit, GAiT is chairing this morning's session entitled "Developing iPSC Differentiation to Efficently Create the Desired Cell Type".

Image for twitter card

iPSC Manufacturing Summit 2022

Join us in Boston for the iPSC Manufacturing Summit, the only forum dedicated to optimizing the scalable manufacture...

www.ipsc-manufacturing-summit.com

Reply on Twitter 1552560791823564800 Retweet on Twitter 1552560791823564800 1 Like on Twitter 1552560791823564800 0 Twitter 1552560791823564800
IPSCtherapies avatar; GAiT @IPSCtherapies ·
27 Jul 1552240385417793538

GAiT is happy to chair this morning's session entitled "Equipping iPSC Expansion Practices to Cater for Scale-Up & Commercialization" at the iPSC Manufacturing Summit http://www.ipsc-manufacturing-summit.com

Image for the Tweet beginning: GAiT is happy to chair Twitter feed image.
Reply on Twitter 1552240385417793538 Retweet on Twitter 1552240385417793538 0 Like on Twitter 1552240385417793538 1 Twitter 1552240385417793538
IPSCtherapies avatar; GAiT @IPSCtherapies ·
22 Jul 1550423144112037893

iPSC Quality Round Participants have received automated emails regarding manuscript submission this week. We would be grateful if you can respond to these. If you have already done so, thank you.

Reply on Twitter 1550423144112037893 Retweet on Twitter 1550423144112037893 0 Like on Twitter 1550423144112037893 1 Twitter 1550423144112037893
IPSCtherapies avatar; GAiT @IPSCtherapies ·
21 Jul 1550056204738641920

GAiT will speak at the iPSC Manufacturing Summit in Boston next week. Details at http://www.ipsc-manufacturing-summit.com

Image for the Tweet beginning: GAiT will speak at the Twitter feed image.
Reply on Twitter 1550056204738641920 Retweet on Twitter 1550056204738641920 0 Like on Twitter 1550056204738641920 1 Twitter 1550056204738641920
Load More...

Invite Users to Site

Invite another user onto the GAiT Website
Invite Users

Social media

Follow us on social media

GAiT LinkedIn GAit Sound Cloud GAiT Twitter

 

 

Newsletter





© 2022 GAiT. All Rights reserved. Web Design by Conceptstore
  • Home
  • Portal Login